|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1004758277 |
003 |
OCoLC |
005 |
20231120010220.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
170927s2017 enk ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d N$T
|d IDEBK
|d OPELS
|d N$T
|d MERER
|d OCLCF
|d OCLCQ
|d UPM
|d NLE
|d D6H
|d OCLCQ
|d U3W
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d SFB
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1004672675
|a 1004946003
|
020 |
|
|
|a 9780081004982
|q (electronic bk.)
|
020 |
|
|
|a 0081004982
|q (electronic bk.)
|
020 |
|
|
|z 0081004966
|
020 |
|
|
|z 9780081004968
|
035 |
|
|
|a (OCoLC)1004758277
|z (OCoLC)1004672675
|z (OCoLC)1004946003
|
050 |
|
4 |
|a RD598.35.S73
|
072 |
|
7 |
|a MED
|x 085000
|2 bisacsh
|
082 |
0 |
4 |
|a 617.4/130592
|2 23
|
245 |
0 |
0 |
|a Functionalized cardiovascular stents /
|c edited by J. Gerard Wall, Halina Podbielska, Magdalena Wawrzy�nska.
|
260 |
|
|
|a Duxford, United Kingdom :
|b Woodhead Publishing,
|c 2017.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Woodhead Publishing series in biomaterials
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a Cardiovascular disease is a major cause of mortality in the western world and about half of these deaths are caused by coronary artery disease. One of the most commonly used interventions to treat arterial blockages is to deploy an arterial stent to keep the vessel open. Traditionally, some cardiovascular stents have been associated with serious side-effects, such as thrombosis. This book describes the fundamentals of cardiovascular stents, technologies to functionalize their surfaces and the market status of these important implants. The chapters provide specific focus on the production and evolution of cardiovascular stents, providing essential knowledge for researchers on advances in the field and knowledge of how cardiovascular stents are currently being "functionalized" in order to improve their biocompatibility and minimize negative outcomes in vivo
|
588 |
0 |
|
|a Vendor-supplied metadata.
|
650 |
|
0 |
|a Stents (Surgery)
|
650 |
|
0 |
|a Cardiovascular system
|x Surgery.
|
650 |
|
2 |
|a Cardiovascular Surgical Procedures
|0 (DNLM)D013504
|
650 |
|
6 |
|a Appareil cardiovasculaire
|x Chirurgie.
|0 (CaQQLa)201-0008311
|
650 |
|
7 |
|a MEDICAL
|x Surgery
|x General.
|2 bisacsh
|
650 |
|
7 |
|a Cardiovascular system
|x Surgery
|2 fast
|0 (OCoLC)fst00847239
|
650 |
|
7 |
|a Stents (Surgery)
|2 fast
|0 (OCoLC)fst01133063
|
700 |
1 |
|
|a Wall, J. Gerard.
|
700 |
1 |
|
|a Podbielska, Halina.
|
700 |
1 |
|
|a Wawrzy�nska, Magdalena.
|
776 |
0 |
8 |
|i Print version:
|t Functionalized cardiovascular stents.
|d Duxford, United Kingdom : Woodhead Publishing, 2017
|z 0081004966
|z 9780081004968
|w (OCoLC)978604692
|
830 |
|
0 |
|a Woodhead Publishing series in biomaterials.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780081004968
|z Texto completo
|